Delivery Order SPE2DR25D2104-SPE2DR26F3REQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,964.50. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location, utilizing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count packaging) valued at $11,679.67 under a firm fixed-price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count supply) valued at $17,735.23. This firm fixed-price contract, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 2.5 mg tablets in a 60-count package, valued at $1,474.20 under a firm fixed-price contract. This non-set-aside award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count) valued at $11,346.62 on November 26, 2025, with completion targeted for November 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply contract. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,768.30 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,965.60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) under a firm fixed price contract. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement and is issued as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract value of $2,049.36. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,961.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets in a quantity of 60 units. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of November 14, 2025. The award was made on November 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3REQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed-price contract valued at $1,902.96. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply services to federal military and healthcare systems, with performance executed from the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the company to supply a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current award of ELIQUIS, an anticoagulant medication, exemplifies the vendor's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/10/25 |